Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Endovascular Recanalization for Acute Basilar Artery Occlusion With Extended Time Window (ANGEL-BAO)
NCT06101667Active, not recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Nov 2023
- Primary completion
- Mar 2026
- Countries
- 1
01
Overview
Randomised, open-label trial in ischemic stroke and basilar artery occlusion (BAO) (2 arms), sponsored by Beijing Tiantan Hospital. Primary endpoint: Rate of modified Rankin scale 0-3 at 90 days. Started Nov 2023; status: active, not recruiting.
02
Conditions
ischemic strokebasilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT06101667.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06101667.